Senator Investment Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100,000
Closed -$12.4M 74
2023
Q4
$12.4M Buy
+100,000
New +$10.2M 0.53% 49
2022
Q2
Sell
-300,000
Closed -$38.4M 62
2022
Q1
$38.4M Buy
+300,000
New +$32.8M 1.19% 28
2021
Q1
Sell
-700,000
Closed -$64.7M 134
2020
Q4
$64.7M Buy
700,000
+200,000
+40% +$17.9M 1.22% 28
2020
Q3
$51.5M Buy
+500,000
New +$52.2M 1.5% 30

Other funds holding DXCM

Senator Investment Group's DXCM Position: Q1 2024 in Review

Senator Investment Group sold out of DexCom (DXCM) in Q1 2024, closing a stake of 100,000 shares — an estimated $12.4M sold.

Senator Investment Group first reported a position in DXCM in Q3 2020 and held it in 4 quarters. The position peaked at $64.7M in Q4 2020. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Senator Investment Group reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Senator Investment Group sold 100,000 DexCom shares in Q1 2024, an estimated $12.4M.
  • Senator Investment Group first reported a position in DexCom in Q3 2020 and held it in 4 quarters.
  • Senator Investment Group's DexCom position peaked at $64.7M in Q4 2020.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Senator Investment Group's 13F filing for Q1 2024, filed 14 May 2024.